nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.04.2008 | Editorial

GMP—three letters with many interpretations

Protection of patients or killing the clinical and research applications of PET?

verfasst von: Bengt Långström, Per Hartvig

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Excerpt

The purpose of good manufacturing practise (GMP) is not to place patients at risk due to inadequate safety and efficacy (and to hamper fraud) (Eudralex IV). These principles taken as long back as to Aristotle’s “not to do harm to patients” are non-inevitable and non-disputable. But, which is the best way to fulfil this in the production of radiopharmaceuticals particularly for those evolving to become the molecular tools for positron emission tomography (PET)? …

Titel: GMP—three letters with many interpretations
Protection of patients or killing the clinical and research applications of PET?
verfasst von: Bengt Långström
Per Hartvig
Publikationsdatum: 01.04.2008
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 4/2008
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-007-0657-1

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2008

Pharmacological evaluation of [123I]-CLINDE: a radioiodinated imidazopyridine-3-acetamide for the study of peripheral benzodiazepine binding sites (PBBS)

Whole body [11C]-dihydrotetrabenazine imaging of baboons: biodistribution and human radiation dosimetry estimates

Radiation dosimetry and biodistribution of 11C-ABP688 measured in healthy volunteers

131I-MIBG Therapy in metastatic phaeochromocytoma and paraganglioma

Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases

PET imaging with hypoxia tracers: a must in radiation therapy